Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United States - Takeaways - MDSpire

Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United States

  • By

  • Ayako Wendy Fujita

  • C Christina Mehta

  • Qian Yang

  • Tina T Tisdale

  • Maria L Alcaide

  • Aadia Rana

  • Deborah J Konkle-Parker

  • Daniel Westreich

  • Seble G Kassaye

  • Elizabeth F Topper

  • Anandi N Sheth

  • April 9, 2025

  • 0 min

Share

  • 1

    Substance use (SU) is prevalent among reproductive-age women with and without HIV in the Southern United States, with significant rates of drug and alcohol use.

  • 2

    Among 891 women studied, 12% reported past-year drug use, 15% hazardous alcohol use, 37% tobacco use, and 45% cannabis use.

  • 3

    Pregnant women reported lower rates of past-year drug use (7%) but notable rates of hazardous alcohol (12%) and cannabis use (39%).

  • 4

    16% of women with past-year drug use experienced accidental overdose, and 23% accessed any drug treatment program in the past year.

  • 5

    Implementation studies are necessary to identify barriers to integrating substance use disorder care into HIV treatment for reproductive-age women.

Original Source(s)

Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United States

  • by Ayako Wendy Fujita, C Christina Mehta, Qian Yang, Tina T Tisdale, Maria L Alcaide, Aadia Rana, Deborah J Konkle-Parker, Daniel Westreich, Seble G Kassaye, Elizabeth F Topper, Anandi N Sheth

  • April 9, 2025

Related Content

RFK Jr. pledged transparency, but some info remains hidden

Urgent response is needed to address the stimulant-fentanyl related overdose crisis

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.